Skip to main content
. 2021 Feb 26;16(2):e0247653. doi: 10.1371/journal.pone.0247653

Table 4. Adverse events.

Nausea, n nVNS   P(exact)
  None Yes   0.50
Sham None 1 0 1
Yes 2 13 15
  3 13 16
Constipation, n nVNS   P(exact)
  None Yes   1.00
Sham None 1 0 1
Yes 0 15 15
  1 15 16
Vomit, n   nVNS   P(exact)
  None Yes   0.50
Sham None 0 0 0
Yes 2 14 16
  2 14 16
Dizziness, n nVNS   P(exact)
  None Yes   0.63
Sham None 1 1 2
Yes 3 11 14
  4 12 16
Headache, n nVNS   P(exact)
  None Yes   1.00
Sham None 0 2 2
Yes 2 12 14
  2 14 16
Fatigue, n   nVNS   P(exact)
  None Yes   1.00
Sham None 3 1 4
Yes 2 10 12
  5 11 16
Abdominal pain, n nVNS   P(exact)
  None Yes   0.38
Sham None 1 1 2
Yes 4 10 14
  5 11 16
Diarrhoea, n nVNS   P(exact)
  None Yes   1.00
Sham None 1 1 2
Yes 2 12 14
  3 13 16
Dry mouth, n nVNS   P(exact)
  None Yes   1.00
Sham None 2 0 2
Yes 1 13 14
  3 13 16
Itching, n   nVNS   P(exact)
  None Yes   1.00
Sham None 0 1 1
Yes 0 15 15
  0 16 16
Other, n   nVNS   P(exact)
  None Yes   0.25
Sham None 0 0 0
Yes 3 13 16
  3 13 16

Note: Distribution of specific adverse events after nVNS and sham treatment (None: No adverse events; Yes: Adverse events noted).

Abbreviations: n = number of patients.